Using smartphones to test cognitive health for early signs of dementia
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment
This study is testing a new app that helps older adults and their doctors easily check how well their brains are working, so they can spot any early signs of memory issues or dementia and take action sooner.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Parabon Nanolabs, INC. NIH-funded |
| Lab location | 1 site (Reston, United States) |
| Project ID | NIH-10478979 on NIH RePORTER |
What this research studies
This research focuses on developing a smartphone and tablet-based platform called CTX that allows for the collection and analysis of cognitive performance measurements. By utilizing mobile sensors, the platform enables users to conduct cognitive tests anytime and anywhere, providing a more frequent and precise assessment of cognitive abilities. This approach aims to detect early changes that may indicate mild cognitive impairment or early dementia, facilitating better monitoring and management of cognitive health. The goal is to empower aging adults and their clinicians with tools for early intervention and planning.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are concerned about their cognitive health or are at risk for dementia.
Not a fit: Patients who are not experiencing any cognitive issues or who are under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of cognitive decline in aging adults.
How similar studies have performed: Other research has shown promise in using mobile technology for cognitive assessments, indicating that this approach could be effective.
Where this research is happening
Reston, United States
- Parabon Nanolabs, INC. — Reston, United States (Active)
Researchers
- Principal investigator: Armentrout, Steven L — Parabon Nanolabs, INC.
- Study coordinator: Armentrout, Steven L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.